conston‘ blog
Know what's New
Qingdao Conston Medical Technology Co.,ltd is a professional medical devices manufacture, that is committed to innovation, quality and excellence, our company aspires to consistently provide customers with the finest products, competitively priced and backed by world-class customer care. We continuously strive to be the best medical device manufacturing company to ensure our customers can rely on our products to ultimately improve the lives of the patients they serve.
-
May 25, 2024
APPLIERRS FOR POLYMER LIGATING CLIPS
APPLIERRS FOR POLYMER LIGATING CLIPS
-
May 15, 2024
Medtronic Surgical Robots (Mazor Robotics), layoffs in Israel
Medical device giant Medtronic will lay off 35 people in Israel, or about 3% of the Israeli workforce (about 1,200 employees). Most of the layoffs in Israel will come from Mazor Robotics, which Medtronic acquired to develop robotic navigation systems for spinal surgery.
-
May 14, 2024
FDA: Johnson & Johnson discontinued use of this product
On May 10, 2024, the U.S. Food and Drug Administration (FDA) announced that Johnson & Johnson's Megadyne is voluntarily recalling its ultra-soft pediatric patient reflux electrode and discontinuing use of the product. Megadyne withdrew the product after reports of burns in patients using the electrodes. Root cause investigations include tests that show potential heat damage when multiple factors are present together.
-
Apr 28, 2024
2300 units: Mindray wins a large order in the United States
On January 11, 2024, Mindray announced a five-year agreement with WakeMed Health & Hospitals (WakeMed), North Carolina, the 970-bed healthcare system, which has selected Mindray monitors for three of its hospitals. Including Mindray BeneVision Central Monitoring System (DMS) and BeneVision N series monitors.
-
Apr 09, 2024
JOHNSON & JOHNSON's SHOCKWAVE takeover
Recently, Johnson & Johnson Medical Technology once again demonstrated its determination to expand its cardiovascular product line, with the acquisition of Shockwave Medical at a high price of $13.1 billion, further consolidating its leading position in the cardiovascular field. The deal follows the late 2022 acquisition of mini heart pump maker Abiomed, a $16.6 billion acquisition, and the 23-year $400 million acquisition of Laminar, a heart implant developer designed to reduce patients' long-term risk of stroke due to atrial fibrillation
-
Apr 08, 2024
Haemonetics Cardiovascular Intervention Circuit invested $1 billion
On April 1, 2024, Haemonetics Corporation, a global blood technology giant, announced that it has completed the acquisition of Attune Medical, a manufacturer of esophageal cooling devices. The acquisition includes an upfront payment of $160 million, as well as certain milestone payments.
